-

AGCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AGCO Corporation (AGCO)

AGCO Corporation guided investors to full-year 2026 sales of $10.5-$10.7 billion and adjusted EPS of $5.80-$6.10. On July 30, 2026, those figures were cut -- and shares fell. Levi & Korsinsky is investigating potential securities law violations.

NEW YORK--(BUSINESS WIRE)--A guidance gap of roughly $400 million to $500 million in sales, and up to $0.35 per share in earnings, is what AGCO Corporation (NYSE: AGCO) investors were handed on July 30, 2026, when the Company reduced its full-year 2026 outlook alongside second-quarter results and the stock declined. If you suffered a loss on your AGCO investment, you are encouraged to submit your information for a free case evaluation. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The prior outlook, in place going into the second quarter, called for net sales of $10.5-$10.7 billion and adjusted earnings per share of $5.80-$6.10. The revised outlook issued July 30, 2026 called for net sales of $10.1-$10.2 billion and adjusted EPS of $5.50-$5.75.

On the Company's May 5, 2026 earnings call, Chief Executive Officer Eric Hansotia described AGCO as "executing a deliberate and measured step-down in production as the year progresses." Chief Financial Officer Damon Audia stated on the same call that the margin and earnings-per-share outlook "do not assume any refunds related to the EPA tariff." AGCO's subsequent disclosures reflected an increase in expected tariff costs of approximately $25 million.

Investors who lost money on AGCO shares are encouraged to have their losses reviewed at no cost, or contact Joseph E. Levi, Esq. at (212) 363-7500.

Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com

Frequently Asked Questions About the AGCO Investigation

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether AGCO Corporation made materially false or misleading statements regarding its full-year 2026 sales and earnings outlook, its planned production step-down, and expected tariff-related costs. Following the July 30, 2026 reduction to full-year guidance, the stock price declined.

Q: When did AGCO allegedly mislead investors? A: The investigation concerns statements made before the July 30, 2026 disclosure that allegedly caused investors to purchase securities at inflated prices.

Q: Who is eligible to participate in the AGCO investigation? A: Investors who purchased AGCO stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do AGCO investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my AGCO shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AGCO and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis. No upfront fees, no retainer, and no out-of-pocket costs.

Q: What if I live outside the United States? A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

Attorney Advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NYSE:AGCO

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)

NEW YORK--(BUSINESS WIRE)--On May 5, 2026, Myriad Genetics (NASDAQ: MYGN) reaffirmed adjusted EBITDA of $37 million to $49 million and adjusted gross margin of 68% to 69% for full-year 2026. Roughly three months later, the adjusted EBITDA range was suspended outright and MYGN shares dropped. If you held Myriad Genetics stock and lost money, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (2...

MO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Altria Group (MO)

NEW YORK--(BUSINESS WIRE)--Altria Group (NYSE: MO) shareholders took losses in late July 2026 when the Company reported second-quarter earnings and revenue below consensus and cut its full-year outlook -- an outlook management had reaffirmed on April 30, 2026 at adjusted diluted EPS of $5.56 to $5.72. If you suffered a loss on your Altria Group investment, you are encouraged to click here to submit your Altria loss information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikor...

TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)

NEW YORK--(BUSINESS WIRE)--Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 billion, Teladoc Health (NYSE: TDOC) reduced that outlook to $2.36 billion to $2.45 billion, and shares fell nearly 30%. If you lost money holding Teladoc Health shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.On the February 25, 2026 fourth qua...
Back to Newsroom